syngo.via Prostate MR Job Aid

SIEMENS Healthineers syngo.via Prostate MR Job Aid Template Effective Date: 27 May 2019 | HOOD05162003010284 Job Aid Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 syngo.via Prostate MR Job Aid SIEMENS Healthineers Table of Contents Overview 3 MR Prostate Q + MR Prostate Reading Confirmation Layout 4 Single Learn Segments Biopsy Support Input Data 5 Prostate Prostate RFP Suspicion Map 6 Viewing MR Spectro Analysis MR Tissue4D Analysis Confirming Lesions 7 Findings and Reporting 8 Findings Prostate AF MR_1 MR Prostate 1 Lesion 2 MR_1 Volume 39.67 cm3 Configuration 9 Volume 1.26 cm3 Min / Max: 0.00 /1275.00 Gland Volume 69.84 ... Min / Max: 24.00 /707.00 Mean/SD: 380.62 /173.99 Preview for Lesion 1 VVD Mean/SD: 250.51 /92.25 MR_1 Volume 39.67 cm3 Min / Max: 0.00 /1275.00 Mean/SD: 380.62 /173.99 Volume 1.26 cm3 Additional Information 10 Lesion 1 MR_1 Volume 1.26 cm3 Region Min / Max: 24.00 /707.00 TZa Mean/SD: 250.51 /92.25 Laterality Left Location Apical RFP T2W RFP DWI Tools DCE L Gland Volume_1 MR_1 Volume 69 84 cm3 EPE Hide Hide Lines Reset Min / Ma 2 of 2 Results. Graphics Timepol ... Mean/S[ Score 5 Level of Suspicion 4.90000009536743 Edit Snapshot Print Export Undo Redo Score 5 Score 5 Index Lesion Layout Image Image V V 2:00 PM Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 2 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Overview SIEMENS Healthineers In the MR Prostate workflow, you can read and MR Prostate MR Prostate Reading analyze images of the prostate. Single Leam Biopsy Support Prostate The MR Prostate workflow has 2 preconfigured Prostate RFP Viewing MR Spectro Analysis MR Tissue4D Analysis reading steps: V • Prostate • Viewing Findings Prostate MR 1 MR Prostate 1 Lesion 2 MR_1 Volume 39.67 cm3 Volume 1.26 cm3 Min / Max: 0.00 /1275.00 Gland Volume VVD 69.84 .. Min / Max: 24.00 /707.00 Mean/SD: 380.62 /173.99 Preview for Lesion 1 Mean/SD: 250.51 /92.25 MR 1 Volume 39.67 cm3 Min / Max: 0.00 /1275.00 Volume 1.26 cm3 Mean/SD: 380.62 /173.99 Lesion 1 MR_1 Volume 1.26 cm3 n TZa Region Min / Max: 24.00 /707.00 Prostate Lesions is an optional functionality that Mean/SD: 250.51 /92.25 aterality Left Location Apical can be purchased for the workflow. RFP T2W DWI Tools DICE If available, during pre-processing Gland Volume_1 MR_1 EPE Volume 69 84 cm.3 Synch Align Full Text Graphie Hide Line: Rezet Min / Ma 2 of 2 Results. Mean/S[ Score 5 The prostate is segmented Lesion Lesion 2 Level of Suspicion 4.90000009536743 • Score 5 Score 5 Index Lesion Edit Snapshot Print Export Layout Image Image V V Potential lesions are detected 2:00 PM • • Potential lesions are classified with a score • Uses PI-RADS report Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 3 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Confirmation Layout SIEMENS Healthineers In the MR Prostate Reading step, select the Prostate Lesions icon. Prostate Lesions This opens a new layout, which guides the user in verifying and confirming the possible lesions. The layout shows the input images: T2 transversal, high (calculated) b-value image, ADC map, dynamic T1 and T2 sagittal in dual monitor setup. AF Gland Volume Volume 38.98 cm3 Preview for Lesion 1 In the lower row, a fusion of the transversal T2 series and the Min / Max: 0.00 /701.00 Mean/SD: 182.30 /67.71 Volume 25.38 cm3 Min / Max: 0.00 /603.00 1 Volume 0.23 cm3 Mean/SD: 168.65 /59.80 Suspicion Map, the prostate contour, the non-peripheral zone, and Region PZpl Volume 0.29 cm3 Laterality Right contours of the potential lesions is displayed. Min / Max: 81.00 /233.00 Mean/SD: 145.92 /21.25 Location Medial T2W In the Lesions Preview segment, the details of the currently DWI selected lesion candidates are displayed. DCE EPE 3 of 3 Results. Score 4 Lesion 1 Lesion 2 Lesion 3 Level of Suspicion 4 Score 4 Score 4 Score 4 Index Lesion If necessary, it is possible to add another series from the Series V Navigator. The common measurement tools, including Mean Curve, are available. Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. Please 4 contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Input Data SIEMENS Healthineers For successful lesion detection, the system requires images from a 1.5 Tesla or 3 Tesla system. As a T2 sequence type, T2 Turbo Spin Echo or SPACE series are used. As diffusion-weighted images, ep2d, RESOLVE, or ZOOMit sequence can be used. From diffusion-weighted images, at least two different b-values are required. As a low b-value b50 is recommended and as a high b-value around 1,000 is recommended. Based on all the input data, the system calculates a Suspicion Map, which displays the potential lesions. Scan parameter Value Field strength 1.5 T – 3 T T2 sequences T2 TSE or SPACE Orientation of T2 and DWI series Transversal (strict transversal or anatomical) DWI b-values Low b-value: 0 – 100 (recommended: b=50) High b-value: ≥ 800 (recommended: around 1,000) Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 5 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Suspicion Map SIEMENS Healthineers The Suspicion Map is calculated by a deep learning MR 1 AF Volume 25.38 cm3 Series Min / Max: 0.00 /603.00 Mean/SD: 168.65 /59.80 Add Study algorithm, using the T2-weighted and diffusion- # | Series Name Suspicion Map ? X Current weighted images as input. The Suspicion Map is MR_Prostate_Lesions AF Rad. Univ. Klinik Freiburg MR, 6/12/2017 Germany_MAC Ref.: CongressHighlightsBrochure Pathology_GRASP Tissue4D *1/1/1944, M, 73Y Magnetom Vida t2_tse_sag_p2_384_h_f black if no lesions are detected. 6/12/2017 VB50B Suspicion Map 4 t2_tse_tra_p3_384 #XA10 STUDY ID 3aaaa0179 Gland Volume MR 1 10:47:35 AM ep2d_diff_b50_400 800 tr ... Volume 38.98 cm3 1004 IMA 1 FRM 10/25 ep2d_diff_b50 400 800 tr ... The Suspicion Map is a parametric map that can be Min / Max: 0.00 /701.00 Mean/SD: 182.30 /67.71 ........................ t1_tse tra 3mm t1_vibe-grasp_fs_tra_dyn_S ... fused with a morphological series. 1 cm 10 ... = Suspicion Map R 20 SL 3.0 F It can be sent to PACS if the setting is selected in the Lesion 2 MR_1 TR 7500.0 TP H19 Volume 0.05 cm3 ....................... SP H9.8 Min / Max: 112.00 /249.00 TA 03:37 FoV 200*200 MR Prostate workflow properties. Mean/SD: 192.15 /25.39 p3 NAVAIL/T2/NORM/SH/FIL/DIS2D 691*768s | Tra>Cor(10) B3,4;57,8 Zoom 1.35 177 *tse201_25/160 ProstateAl 80 If the preprocessing fails, the Suspicion Map is not available in the Series Navigator. For possible failure reasons, see page 10. Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 6 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Confirming Lesions SIEMENS Healthineers The lesion candidates are listed in the lower left segment. Grand Volume Volume:38:98 cm3 Min /Max 0:007701 00 Preview for Lesion 1 Mean/SD: 182 30/87 71 Volume 25:38 cm3 Min / Max 0.00/803 Volume 0.23 cm. Mean/SD. 168.85 /5 Region PZpl Laterality Right The details of the currently selected lesion are displayed in the Preview segment. Location Medial T2W DWI 3 of 3 Results. DICE All the lesion candidates: Lesion 1 Lesion 2 Lesion 3 of 3 Results. EPE Score 4 Score Score 4 Score 4 4 Lesion 1 Lesion 2 best of Sulgioun Score 4 Need to be confirmed or deleted Score 4 Score 4 Index Lesion • V V V V • Confirmed lesions are pre-populated in the Findings Assistant and the report, including Volume, Region, Laterality, Location, Score, and the Level of Suspicion. In the lesion tabs, the lesion with the highest score is shown as the first one. When the lesion tab is selected, the lesion candidate is displayed in all the segments of the layout. In the lesion Preview segment, the details of that selected lesion are displayed. They can be changed if necessary. Besides the lesion score, a Level of Suspicion is calculated for each lesion. This level of suspicion provides a more granular assessment of lesion suspiciousness than the lesion score. The level of suspicion may support you when validating the results. It will not be part of the findings information or reporting. The information text No lesion candidates are open for validation will be displayed when all potential lesions are confirmed or rejected. If no lesions are detected, this information text is also displayed. Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 7 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Findings and Reporting SIEMENS Healthineers All the added findings are part of the final report. The Findings Assistant is pre-populated with the Gland Volume, confirmed lesions, and the location of the lesions. These will also be displayed in the report. Details Prostate Current 6/12/2017 O Attributes that are filled in automatically are indicated by . Check that the attributes are correct. Prostate comment Biochemical Results Gland Volume (cm2) : 38.98 Prior Biopsy The findings can be edited. In the prostate template level, Gland Volume can be edited Last Biopsy Date PSA (ng/ml) PSA Density (ng/ml2) & 2.00 Comment Global PI-RADS and the PSA value can be added. When the PSA value is added, the PSA Density is Affected Regions Seminal Vesicles Lymphnodes Neurovasc. Bundle Bones calculated automatically. Hemorrhage Hemorrhage In the findings level, the findings values and score can be edited. Each lesion subscore can Distribute Insert Format Table MR PI-RADS 2 Report be filled. The PI-RADS guideline is used when filling the subscores. IMR PI-RADS 2 Report Patient Demographics ( MR_Prostate_Lations ] 1 6/12/20171 Patient ID [ Germany_MAC ] The broken link icon indicates that this specific combination of score and subscore does Birth Date [ 1/1/1044 ] [ 73 years ] Assessm Prostate not follow the recommendations of the PI-RADS guideline. The broken link icon is also Biochemical Results PSA Density Inglmis OHb&l PH-RADs displayed when subscores are not used. Details Pelvis MR Prostate 1 Current 6/12/2017 Type MR Prostate Attributes that are filled in automatically are indicated by . Check that the attributes are correct. All the findings and information in the Findings Assistant will be Region TZa Laterality left O Location Basal Base part of the report, which is a one pager. With Save and Send, T2W 3 DWI 3 DICE all the findings and the report will be sent to PACS, if configured in EPE No Mid PI-RADS 3 Index Lesion the Administration Portal. Overall Rating BOO Comment Apex Marter Tools Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 8 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Configuration SIEMENS Healthineers The configuration properties can be found in the MR Prostate MR Prostate Workflow Properties ? x Workflow Properties. In the MR Prostate Reading step, click the settings icon to open the Workflow Step Editor Workflow Configuration MR Prostate Workflow Properties dialog box. VInclude MR Spectro Analysis into MR Prostate Workflow Select the Workflow Configuration tab. Perform Automated Prostate Segmentation during pre-processing Publish Suspicion Map upon Save and Send Enable Auto Detection of input series for lesion detection Morphology Diffusion Weighted The configuration of the automatic lesion detection can be Series Descriptions Series Descriptions t2_tra diff performed by a clinical administrator. t2_tse_tra • Perform Automated Prostate Segmentation during Add Remove Remove pre-processing. This is a mandatory setting. • Publish Suspicion Map upon Save and Send. This is not activated by default. When this is activated, the Suspicion Map will be sent and archived to PACS. OK Apply Cancel • Enable Auto Detection of input series for lesion detection. The system searches for T2-weighted and diffusion-weighted series, based on DICOM attributes. When this setting is deselected, you can add a series description for the series to be used. Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 9 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 Prostate MR Additional Information SIEMENS Healthineers Please note: • Good and sufficient image quality of the input data is important. Please validate the quality of the images prior to using them for lesion detection. Insufficient image quality can lead to incomplete or incorrect prostate lesion detection • Validation of the segmentation is important • Validation of the lesions is important • Only lesions classified with score 3, 4, or 5 are displayed • The Suspicion Map will not be updated when some lesions are deleted or not approved Prostate MR Possible User Messages Pre-processing may fail if the image data to be used for the segmentation is not available. In this case, a user message appears, explaining the reason for failure. If pre-processing fails, there is no Suspicion Map in the Series Navigator and the Preview segment is empty. Prostate MR is not commercially available in some countries, e.g., the US. Due to regulatory reasons, future availability cannot be guaranteed. 10 Please contact your local Siemens Healthineers organization for further details. Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021 SIEMENS Healthineers Please note that the learning material is for training purposes only. For the proper use of the software or hardware, please always use the Operator Manual or Instructions for Use (hereinafter collectively “Operator Manual”) issued by Siemens Healthineers. This material is to be used as training material only and shall by no means substitute the Operator Manual. Any material used in this training will not be updated on a regular basis and does not necessarily reflect the latest version of the software and hardware available at the time of the training. The Operator Manual shall be used as your main reference, in particular for relevant safety information like warnings and cautions. Please note: Some functions shown in this material are optional and might not be part of your system. Certain products, product related claims or functionalities (hereinafter collectively “Functionality”) may not (yet) be commercially available in your country. Due to regulatory requirements, the future availability of said Functionalities in any specific country is not guaranteed. Please contact your local Siemens Healthineers sales representative for the most current information. The reproduction, transmission or distribution of this training or its contents is not permitted without express written authority. Offenders will be liable for damages. All names and data of patients, parameters and configuration dependent designations are fictional and examples only. All rights, including rights created by patent grant or registration of a utility model or design, are reserved. © Siemens Healthcare GmbH 2021 Siemens Healthineers Headquarters Siemens Healthcare GmbH Henkestr. 127 91052 Erlangen, Germany Telephone: +49 9131 84-0 siemens-healthineers.com 11 Effective Date: 12 Jul 2021| HOOD05162003206914 Unrestricted © Siemens Healthineers, 2021